Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Haas

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
Pediatric Rheumatology Online Journal|November 30, 2021
Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medicationBoris Hügle, Manuela Krumrey-Langkammerer, Johannes-Peter Haas
Pediatric Rheumatology Online Journal|September 15, 2016
Treatment with high-dose recombinant human hyaluronidase-facilitated subcutaneous immune globulins in patients with juvenile dermatomyositis who are intolerant to intravenous immune globulins: a report of 5 casesFabian Speth, Johannes-Peter Haas, Claas H Hinze
Pediatric Rheumatology Online Journal|January 17, 2013
Treatment preferences in juvenile idiopathic arthritis - a comparative analysis in two health care systemsBoris Hugle, Johannes-Peter Haas, Susanne M Benseler
Gait & Posture|September 16, 2018
Combined three-dimensional gait and plantar pressure analyses detecting significant functional deficits in children with juvenile idiopathic arthritisJosephine Merker, Matthias Hartmann, Johannes-Peter Haas, et al.
Journal of Health Psychology|March 17, 2025
The role of fatigue in adolescents' chronic pain: A study on facets of fatigue in young patients with a chronic pain disorderVivien Manteufel, Lea Höfel, Johannes-Peter Haas, et al.
Schmerz (Berlin, Germany)|October 28, 2020
[Medical pain care for children and adolescents with chronic pain in Germany : An inventory]Lea Höfel, Nicole Draheim, Johannes-Peter Haas, et al.
Pediatric Rheumatology Online Journal|October 2, 2025
Treatment after intra-articular corticosteroid injection in juvenile idiopathic arthritis: a survey within the German Society for Pediatric and Adolescent RheumatologySophia Meister, Mathias Georgi, Boris Hügle, et al.
Pediatric Rheumatology Online Journal|October 25, 2024
Duration of effect in treatment of methotrexate intolerance in juvenile idiopathic arthritis using Eye Movement Desensitization and Reprocessing (EMDR) can be improved by Bi-lateral Alternating Stimulation Tactile (BLAST) wristbandsLea Höfel, Bruno Eppler, Johannes-Peter Haas, et al.
Alcoholism, Clinical and Experimental Research|November 18, 2004
Magnesium treatment of primary alcohol-dependent patients during subacute withdrawal: an open pilot study with polysomnographyMagdolna Hornyak, Peter Haas, Johannes Veit, et al.
Rheumatology (Oxford, England)|January 27, 2017
Countermeasures against methotrexate intolerance in juvenile idiopathic arthritis instituted by parents show no effectAndrea Scheuern, Pascal N Tyrrell, Johannes-Peter Haas, et al.
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
Pediatric Rheumatology Online Journal|November 30, 2021
Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medicationBoris Hügle, Manuela Krumrey-Langkammerer, Johannes-Peter Haas
Pediatric Rheumatology Online Journal|September 15, 2016
Treatment with high-dose recombinant human hyaluronidase-facilitated subcutaneous immune globulins in patients with juvenile dermatomyositis who are intolerant to intravenous immune globulins: a report of 5 casesFabian Speth, Johannes-Peter Haas, Claas H Hinze
Pediatric Rheumatology Online Journal|January 17, 2013
Treatment preferences in juvenile idiopathic arthritis - a comparative analysis in two health care systemsBoris Hugle, Johannes-Peter Haas, Susanne M Benseler
Gait & Posture|September 16, 2018
Combined three-dimensional gait and plantar pressure analyses detecting significant functional deficits in children with juvenile idiopathic arthritisJosephine Merker, Matthias Hartmann, Johannes-Peter Haas, et al.
Journal of Health Psychology|March 17, 2025
The role of fatigue in adolescents' chronic pain: A study on facets of fatigue in young patients with a chronic pain disorderVivien Manteufel, Lea Höfel, Johannes-Peter Haas, et al.
Schmerz (Berlin, Germany)|October 28, 2020
[Medical pain care for children and adolescents with chronic pain in Germany : An inventory]Lea Höfel, Nicole Draheim, Johannes-Peter Haas, et al.
Pediatric Rheumatology Online Journal|October 2, 2025
Treatment after intra-articular corticosteroid injection in juvenile idiopathic arthritis: a survey within the German Society for Pediatric and Adolescent RheumatologySophia Meister, Mathias Georgi, Boris Hügle, et al.
Pediatric Rheumatology Online Journal|October 25, 2024
Duration of effect in treatment of methotrexate intolerance in juvenile idiopathic arthritis using Eye Movement Desensitization and Reprocessing (EMDR) can be improved by Bi-lateral Alternating Stimulation Tactile (BLAST) wristbandsLea Höfel, Bruno Eppler, Johannes-Peter Haas, et al.
Alcoholism, Clinical and Experimental Research|November 18, 2004
Magnesium treatment of primary alcohol-dependent patients during subacute withdrawal: an open pilot study with polysomnographyMagdolna Hornyak, Peter Haas, Johannes Veit, et al.
Rheumatology (Oxford, England)|January 27, 2017
Countermeasures against methotrexate intolerance in juvenile idiopathic arthritis instituted by parents show no effectAndrea Scheuern, Pascal N Tyrrell, Johannes-Peter Haas, et al.
Pageof 11